Telix Pharmaceuticals Ratios (2023-2025) | TLX

Ratios Dec2023 Dec2024 Dec2025
Efficiency
Inventory Average (Quarter) 19.58M32.01M
Assets Average (Quarter) 678.82M
Invested Capital (Quarter) 137.41M403.12M405.02M
Leverage & Solvency
Debt Ratio (Quarter) 0.020.38
Valuation
Enterprise Value (Quarter) -87.03M-501.66M-141.87M